Add Yahoo as a preferred source to see more of our stories on Google. https://www.tipranks.com/news/the-fly/crispr-therapeutics-price-target-raised-to-82-from-80-at ...
Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer's disease. The minimally invasive blood test measures phosphorylated Tau (pTau) 181 protein, a ...
Anti-p53 antibodies are antibodies that mistakenly target a patient's own tissues, leading to a growth of solid tumors. Screening for Anti-p53 helps to diagnose throat, bowel and breast cancers ...
INDIANAPOLIS, Dec. 5, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated ...
The U.S. Food and Drug Administration has given approval to Indianapolis-based Roche Diagnostics to market its Hepatitis B test kit. The test kit, Elecsys HBeAg Immunoassay is a lab test used to ...
(RTTNews) - Swiss drug major Roche (RHHBY) announced Wednesday the launch of Elecsys EBV panel in countries accepting the CE Mark. The company said it plans to file for approval with the FDA in the ...
As cyber security requirements expand for the industrial data systems used within the nation's critical infrastructure, the Elecsys zONeGUARD provides a security solution for industrial communication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results